Article
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models
13 Feb 2023
Abstract excerpt
Abstract Combining optimized spike (S) protein-encoding mRNA vaccines to target multiple SARS-CoV-2 variants could improve control of the COVID-19 pandemic. We compare monovalent and bivalent mRNA vaccines encoding B.1.351 (Beta) and/or B.1.617.2 (Delta) SARS-CoV-2 S-protein in a transgenic mouse and a Wistar rat model. The blended low-dose bivalent mRNA vaccine contains half the mRNA of each respective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
